In vitro activity of ceftazidime/avibactam against carbapenem-nonsusceptible Klebsiella penumoniae isolates collected during the first wave of the SARS-CoV-2 pandemic: a Southern Italy, multicenter, surveillance study

OBJECTIVES: Carbapenemase-producing Enterobacterales (CPE) represent a serious threat for human health being frequently resistant to most of available antibiotics classes. Recently, ceftazidime/avibactam (CAZ/AVI) has been approved for treatment of infections by Gram-negative bacteria, including cla...

Descripción completa

Detalles Bibliográficos
Autores principales: La Bella, Gianfranco, Lopizzo, Teresa, Lupo, Laura, Angarano, Rosa, Curci, Anna, Manti, Barbara, La Salandra, Giovanna, Mosca, Adriana, De Nittis, Rosella, Arena, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533593/
https://www.ncbi.nlm.nih.gov/pubmed/36208851
http://dx.doi.org/10.1016/j.jgar.2022.09.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533593/
https://www.ncbi.nlm.nih.gov/pubmed/36208851
http://dx.doi.org/10.1016/j.jgar.2022.09.013

Ejemplares similares